SCHEMBL29045642

SCHEMBL29045642

COC(CC(=O)O)C(=O)OC(C)(C)C

nearest known ligand 0.34

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CA12 O43570 1/20 0.34
CA14 Q9ULX7 1/20 0.34
DGAT1 O75907 1/20 0.33
PARP1 P09874 1/20 0.33
PARP10 Q53GL7 1/20 0.33
PGD P52209 1/20 0.33
CYP2D6 P10635 1/20 0.33
KMT2A Q03164 2/20 0.33
MEN1 O00255 1/20 0.33
GAA P10253 1/20 0.33
ITGA4 P13612 1/20 0.31
ITGB7 P26010 1/20 0.31
AAK1 Q2M2I8 1/20 0.31
SLC22A6 Q4U2R8 1/20 0.31
LMNA P02545 1/20 0.30
TDP1 Q9NUW8 1/20 0.30
CA1 P00915 1/20 0.30
CA2 P00918 1/20 0.30
CA7 P43166 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28237956 0.84 PGD (0.33) CA12CA14PGDCYP2D6KMT2A
SCHEMBL10029741 0.84 ALDH1A1 (0.34) CA12CA14DGAT1CYP2D6KMT2A
SCHEMBL11129055 0.84 PGD (0.33) CA12CA14PGDCYP2D6KMT2A
SCHEMBL18206213 0.81 ALOX15 (0.42) PGDCYP2D6KMT2AMEN1GAA
SCHEMBL28972742 0.81 GABRP (0.36) CYP2D6KMT2AMEN1GAAAAK1
SCHEMBL18206215 0.81 ALOX15 (0.42) PGDCYP2D6KMT2AMEN1GAA
SCHEMBL29045276 0.79 CTSS (0.37) CA12CA14DGAT1CYP2D6KMT2A
SCHEMBL10029749 0.79 CYP2D6 (0.33) CYP2D6
SCHEMBL2646187 0.79 PARP1 (0.40) CA14PARP1PARP10KMT2ASLC22A6
SCHEMBL10404573 0.79 PARP1 (0.40) CA14PARP1PARP10KMT2ASLC22A6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116514788-B Chromone mTOR inhibitor, and pharmaceutical composition and application thereof 贵州医科大学 2025-05-13 CN disclosed
CN-116514788-A Chromone mTOR inhibitor, and pharmaceutical composition and application thereof 贵州医科大学 2023-08-01 CN disclosed